PubRank
Search
About
N A Le
Author PubWeight™ 52.21
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods.
Am J Epidemiol
1990
4.89
2
Cardiovascular disease risk factors among American Indians. The Strong Heart Study.
Am J Epidemiol
1995
2.53
3
Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
J Clin Invest
1986
1.96
4
Risk factors for coronary heart disease in diabetic and nondiabetic Native Americans. The Strong Heart Study.
Diabetes
1992
1.67
5
Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient mice.
Invest Ophthalmol Vis Sci
2000
1.65
6
Effects of exercise training and its cessation on components of the insulin resistance syndrome in obese children.
Int J Obes Relat Metab Disord
1999
1.64
7
Visceral adipose tissue and cardiovascular risk factors in obese children.
J Pediatr
1998
1.49
8
Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey.
J Clin Invest
1982
1.39
9
Dissociation of apoprotein B and triglyceride production in very-low-density lipoproteins.
Am J Physiol
1980
1.24
10
Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
J Clin Invest
1985
1.23
11
Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne.
N Engl J Med
1985
1.15
12
Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis.
J Clin Invest
1987
1.14
13
Direct measurement of apoprotein B specific activity in 125I-labeled lipoproteins.
J Lipid Res
1978
1.07
14
Murine high-fat diet and laser photochemical model of basal deposits in Bruch membrane.
Arch Ophthalmol
2001
1.06
15
Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey.
J Clin Invest
1988
1.05
16
Effect of changing dietary fat saturation on low-density lipoprotein metabolism in man.
Am J Physiol
1981
1.04
17
Visceral adipose tissue and markers of the insulin resistance syndrome in obese black and white teenagers.
Obes Res
2000
1.02
18
Effect of a high carbohydrate diet on apoprotein-B catabolism in man.
Metabolism
1981
0.96
19
Evidence for non-equilibrating pools of apolipoprotein C-III in plasma lipoproteins.
J Lipid Res
1985
0.96
20
Kinetics of chylomicron remnant clearance in normal and in hyperlipoproteinemic subjects.
J Lipid Res
1987
0.95
21
An efficient chromatographic system for lipoprotein fractionation using whole plasma.
J Lipid Res
1998
0.93
22
Radiotracers for low density lipoprotein biodistribution studies in vivo: technetium-99m low density lipoprotein versus radioiodinated low density lipoprotein preparations.
J Nucl Med
1988
0.92
23
Lipoprotein metabolism in nonresponders to increased dietary cholesterol.
Arteriosclerosis
1982
0.91
24
Changes in lipoprotein concentrations during the development of noninsulin-dependent diabetes mellitus in obese rhesus monkeys (Macaca mulatta).
J Clin Endocrinol Metab
1991
0.91
25
Metabolism of apoprotein B in cynomolgus monkey: evidence for independent production of low-density lipoprotein apoprotein B.
Am J Physiol
1983
0.90
26
Evidence for heterogeneity of low-density lipoprotein metabolism in the cynomolgus monkey.
Biochim Biophys Acta
1986
0.87
27
Apo E-mediated uptake and degradation of normal very low density lipoproteins by human monocyte/macrophages: a saturable pathway distinct from the LDL receptor.
Biochem Biophys Res Commun
1985
0.87
28
Kinetic analysis using specific radioactivity data.
Methods Enzymol
1986
0.87
29
Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins.
HIV Med
2005
0.86
30
Meal-induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor α are attenuated by prandial + basal insulin in patients with Type 2 diabetes.
Diabet Med
2011
0.85
31
Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity.
Diabetes Care
1994
0.85
32
Marked overproduction of low density lipoprotein apolipoprotein B in a subject with heterozygous familial hypercholesterolemia. Effect of portacaval shunting.
Biochim Biophys Acta
1982
0.84
33
Familial combined hyperlipidaemia: use of stable isotopes to demonstrate overproduction of very low-density lipoprotein apolipoprotein B by the liver.
J Inherit Metab Dis
1991
0.84
34
Chenodeoxycholic acid normalizes elevated lipoprotein secretion and catabolism in cerebrotendinous xanthomatosis.
J Lipid Res
1989
0.83
35
Concentrations of Lp(a) in black and white young adults: relations to risk factors for cardiovascular disease.
Ann Epidemiol
1994
0.83
36
Protocol for the study of the metabolism of retinyl esters in plasma lipoproteins during postprandial lipemia.
J Lipid Res
1992
0.82
37
Increased low-density-lipoprotein catabolism in myeloproliferative disorders.
Ann Intern Med
1982
0.82
38
Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins.
J Lipid Res
1993
0.82
39
Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size.
J Lipid Res
1999
0.81
40
Altered high density lipoprotein metabolism in patients with myeloproliferative disorders and hypocholesterolemia.
Metabolism
1986
0.80
41
Effect of somatostatin-induced suppression of postprandial insulin response upon the hypertriglyceridemia associated with a high carbohydrate diet.
J Clin Invest
1982
0.79
42
Direct determination of apolipoprotein C-III specific activity using immunoaffinity chromatography.
Methods Enzymol
1986
0.79
43
Protocol for the preparation of a segmental linear polyacrylamide gradient gel: simultaneous determination of Lp[a], LDL, and HDL particle sizes.
J Lipid Res
1997
0.79
44
The effect of lovastatin on very low-density lipoprotein apolipoprotein B production by the liver in familial combined hyperlipidaemia.
J Inherit Metab Dis
1993
0.77
45
Direct measurement of apoprotein C-III specific activity in 125I-labeled very low density lipoproteins using immunoaffinity chromatography.
J Lipid Res
1983
0.77
46
Determinants of fasting plasma triglyceride levels: metabolism of hepatic and intestinal lipoproteins.
Eur J Clin Invest
1992
0.77
47
Increased catabolism of native and cyclohexanedione-modified low density lipoprotein in subjects with myeloproliferative diseases.
Arteriosclerosis
1983
0.76
48
Immunoaffinity isolation of apolipoprotein E-containing lipoproteins.
Biochim Biophys Acta
1985
0.75
49
Juvenile neuronal ceroid-lipofuscinosis: characterization of the dyslipoproteinaemia and demonstration of membrane phospholipid and phospholipid-dependent signal transduction abnormalities in cultured skin fibroblasts.
J Inherit Metab Dis
1993
0.75
50
Cardiovascular disease and hyperlipidaemia.
Curr Opin Lipidol
1994
0.75
51
Hyperlipidemia and cardiovascular disease.
Curr Opin Lipidol
1997
0.75
52
Binding affinity and particle size of LDL in subjects with moderate hypercholesterolemia: relationship with in vivo LDL metabolism.
J Lipid Res
1996
0.75
53
Effect of acute intravenous alcohol on plasma lipoproteins in man.
Metabolism
1991
0.75
54
Hyperlipidaemia and cardiovascular disease.
Curr Opin Lipidol
1999
0.75
55
Hyperlipidaemia and cardiovascular disease.
Curr Opin Lipidol
2001
0.75
56
Protocol for efficient plasma sampling for low density lipoprotein turnover studies.
J Lipid Res
1984
0.75